retatrutide news october 2025 Eli Lilly says next-generation weight loss drug clears crucial obesity trial October 27, 2025: U.K. regulators
Description
GLP-1 medications are considered a highly effective weight loss drug, providing sustainable results for those struggling with obesity
released preliminary topline week 96 results from Phase 2b study HARMONY The study previously met its primary endpoint of 1 stage improvement in fibrosis with no worsening of MASH after 24 weeks of treatment for both the 50mg EFX (41%) and 28mg EFX (39%) dose groups, compared to 20% for the placebo arm
Most of these drugs belong to a class called GLP-1 medication (glucagon-like peptide-1 receptor agonists)
Dietary Modulation of GLP-1 Release and Action The GLP-1 hormone is naturally released in response to eating by intestinal enteroendocrine L-cells, present throughout the intestines and especially the distal colon
Role of TLR4 in the gut-brain axis in Parkinsons disease: A translational study from men to mice
Good examples include whole grains like brown rice, quinoa, and barley
